DOI:
10.1055/s-00000041
Neuropediatrics
LinksClose Window
References
Stolte B, Totzeck A, Kizina K. et al.
Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy.
Ther Adv Neurol Disorder 2018;
11: 1756286418803246
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.